Tag Archives: limited distribution drug

Specialty Pharmacy News Roundup: November 2023

The following company announcements are just a few of the specialty pharmacy company activities from this month. Subscribe to AMI’s Specialty Pharmacy Database to stay up to date on company and industry trends

Specialty Pharmacy News Roundup: September 2023

Subscribe to AMI’s Specialty Pharmacy Database to stay up to date on specialty pharmacy company and industry trends

Specialty Pharmacy Limited Distribution Drug Agreements at Year-End 2022

The leading specialty pharmacies were busy signing limited distribution drug agreements at the end of 2022. Here’s a round-up of the activities

Recent Activities Position AscellaHealth As a Leader in Specialty Pharmaceutical Services

AscellaHealth recently announced a comprehensive suite of Specialty Pharmacy (SP) services, including pre-commercialization, outsourced market access, wholesale, 3PL, limited distribution drug (LDD) fulfillment, and custom Patient Support and HUB Services

Walgreens Investing in Future Growth of Health System Specialty Pharmacies

Walgreens Boots Alliance (WBA) and Shields Health Solutions announced that WBA, through its wholly-owned subsidiary, Walgreen Co., is making a majority investment in Shields, an industry leader in integrated, health system-owned specialty pharmacy care

Acentrus Specialty Providing NERLYNX® to Clients

Acentrus Specialty is a separate  Apexus offering. Apexus is a subsidiary of Vizient, the largest member-driven, health care performance improvement company in the country.

Lundbeck’s Vyepti Distributed by Only Two Specialty Pharmacies

Lundbeck has named AllianceRx and Orsini as the only two specialty pharmacies to distribute Vyepti

Limited Distribution Network for DOPTELET® Includes Biologics by McKesson

Dova recently entered into a merger agreement with Swedish Orphan Biovitrum AB (Sobi)